Word

AGEPHA

Status

Registered

Status Code

700

Status Date

Tuesday, June 2, 2020

Serial Number

88325857

Registration Number

6070487

Registration Date

Tuesday, June 2, 2020

Mark Type

4000

Filing Date

Tuesday, March 5, 2019

Published for Opposition

Tuesday, January 14, 2020

Trademark Owner History

MURRAY & POOLE ENTERPRISES LTD. -
AGEPHA Pharma s.r.o. - Original Registrant

Classifications

5 Pharmaceutical and veterinary preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceuticals, namely, anti-infectives; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for ophthalmological use; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical agents for epidermis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of gout; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations, namely, ophthalmological preparations; Pharmaceutical preparations, namely, preparations for prophylaxes and/or treatment of the cardiovascular system; Dietetic substances adapted for medical use

Trademark Events

Mar 8, 2023

Automatic Update Of Assignment Of Ownership

Jun 2, 2020

Registered-Principal Register

Apr 30, 2020

Notice Of Acceptance Of Statement Of Use E-Mailed

Apr 29, 2020

Allowed Principal Register - Sou Accepted

Apr 24, 2020

Statement Of Use Processing Complete

Apr 9, 2020

Use Amendment Filed

Apr 24, 2020

Case Assigned To Intent To Use Paralegal

Apr 9, 2020

Teas Statement Of Use Received

Mar 10, 2020

Noa E-Mailed - Sou Required From Applicant

Jan 14, 2020

Official Gazette Publication Confirmation E-Mailed

Jan 14, 2020

Published For Opposition

Dec 25, 2019

Notification Of Notice Of Publication E-Mailed

Dec 9, 2019

Assigned To Lie

Dec 6, 2019

Approved For Pub - Principal Register

Nov 12, 2019

Teas/Email Correspondence Entered

Nov 11, 2019

Correspondence Received In Law Office

Nov 11, 2019

Teas Response To Office Action Received

May 21, 2019

Notification Of Non-Final Action E-Mailed

May 21, 2019

Non-Final Action E-Mailed

May 21, 2019

Non-Final Action Written

May 14, 2019

Assigned To Examiner

Mar 22, 2019

New Application Office Supplied Data Entered

Mar 8, 2019

New Application Entered